KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -78.4% | 36,800 | 0.0% | 0.01% | -78.7% |
| Q1 2022 | $51,000 | +2.0% | 36,800 | -11.1% | 0.05% | +34.3% |
| Q4 2021 | $50,000 | -66.0% | 41,400 | -26.2% | 0.04% | -35.2% |
| Q3 2021 | $147,000 | -50.5% | 56,100 | 0.0% | 0.05% | -42.6% |
| Q2 2021 | $297,000 | -60.7% | 56,100 | -50.0% | 0.09% | -13.8% |
| Q1 2021 | $756,000 | +100.0% | 112,200 | +101.1% | 0.11% | -6.8% |
| Q4 2020 | $378,000 | +0.3% | 55,800 | +10.9% | 0.12% | -22.5% |
| Q3 2020 | $377,000 | -28.7% | 50,300 | 0.0% | 0.15% | -14.2% |
| Q2 2020 | $529,000 | -25.8% | 50,300 | -38.0% | 0.18% | -37.4% |
| Q1 2020 | $713,000 | +254.7% | 81,100 | +48.8% | 0.28% | +97.9% |
| Q4 2019 | $201,000 | +13.6% | 54,500 | +17.2% | 0.14% | -34.6% |
| Q3 2019 | $177,000 | -37.7% | 46,500 | +4.5% | 0.22% | -40.1% |
| Q2 2019 | $284,000 | -21.3% | 44,500 | +1.8% | 0.36% | -17.0% |
| Q1 2019 | $361,000 | – | 43,700 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |